Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients

NCT03330990 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Entrectinib
DRUG: Midazolam Hydrochloride

Sponsor

Hoffmann-La Roche